Amarin Corp Plc (AMRN)

[Biobillionair]

No crazier than that

Amarin may be looking to buy Omethra.


PRINCETON, N.J., July 16, 2013 /PRNewswire via COMTEX/ -- The stockholders of Omthera Pharmaceuticals, Inc. OMTH +0.08% (the "Company") voted today at a special meeting of stockholders to adopt the previously announced merger agreement providing for the acquisition of the Company by an affiliate of AstraZeneca PLC.

"Affiliate" not AZN as prior PR's state.



The votes cast by the Company's stockholders in favor of the proposal to adopt the merger agreement represented approximately 88.3 percent of the Company's issued and outstanding common stock entitled to vote as of June 13, 2013, the record date for the special meeting.

http://www.marketwatch.com/story/omthera-stockholders-approve-acquisition-by-astrazeneca-2013-07-16

Orginal PR has no mention of "affiliate".

http://www.reuters.com/article/2013/05/28/us-astrazeneca-omthera-idUSBRE94R04L20130528

To even get more speculative. Amarin announced share offering one day before Epanova's NDA. Share offering netted $120 million which also happens to be the CVR with AZN's purchase agreement made on June 13 th. Timing and amounts raise my suspicion that Amarin and AZN are in advanced negotiations with only the need to value Vascepa's over hang.

The over hang includes Anchor, REDUCEIT, and exclusivity. This may all get obvious if Epnova's application gets an earliy denial of 74 day letter is negative.

My personal opinion is Epanova is a superior bioavailable Lovaza generic and doesn't qualify to file a NDA.

Amarin's JPM meeting could be related to the purchase of Omthera and an "Afiliate" of AZN.

Crazy...maybe

Will